Acquiring convalescent specimens to isolate and identify potent monoclonal antibodies against COVID-19
Study of People Who Have Recovered from COVID-19 to Isolate Monoclonal Antibodies Against COVID-19
Sponsor: Columbia University
Enrolling: Male and Female Patients
Clinic Visits: 1
IRB Number: AAAS9517
Contact: Brett Gray: 000-000-0000 /
Additional Study Information: Due to the high volume of inquiries, please inquire through RecruitMe. A study to isolate and determine the antibody response in patients who have recovered from COVID-19 for the development of monoclonal antibodies for prevention and treatment of coronavirus infections. We are doing this study to develop antibodies against coronavirus to prevent and treat diseases like COVID-19. This study will require one study visit for blood draw in order to examine the antibodies created by your cells, using advanced techniques in the laboratory. If you have been diagnosed with COVID-19 and have recovered, you may be eligible for this study. Due to the volume of inquiries, please send an inquiry through RecruitMe by clicking the "Do You Qualify" button.
This study is closed
David Ho, MD
Do You Qualify?
Are you between the ages of 18-65? Yes No
Have you tested positive for COVID-19? Yes No
You may be eligible for this study

Place Holder

For more information, please contact:
Brett Gray